I am a C-level biotech professional with expertise in drug discovery and development and in the past 10 years in small molecules that modulate RNA biology. My work focuses on advancing therapeutic discovery through the integration of high-content, image-based cell analyses and artificial intelligence, bridging computational biology with experimental validation. By developing visual cell biology platforms, I aim to capture complex cellular phenotypes and translate them into actionable insights for drug development. My background spans drug discovery and development and the application of advanced imaging technologies to uncover regulatory mechanisms at the RNA level. I am particularly interested in therapeutic areas such as inflammation, cancer and neurodegenerative diseases, where RNA biology offers untapped opportunities for intervention. Beyond technical innovation, I am committed to shaping strategy, building collaborative teams, and mentoring the next generation of scientists to drive impactful projects from concept to clinic. My long-term vision is to pioneer integrative approaches that combine small-molecule therapeutics, systems-level data, and AI-driven image analysis, ultimately accelerating the development of transformative treatments.
Anima Biotech, Ltf.
Ramat Gan, Tel Aviv, Israel
Manager
R&D Integrative Solutions, Ness Ziona, Israel
01 Oct 2009 - 01 Oct 2018
President, CEO or Director
ProMining Therapeutics, Ltd., Jerusalem, Israel
01 Oct 2011 - 01 Oct 2015
President, CEO or Director
Fusimab, Ltd., Tel Aviv-Yafo, Israel
01 Jan 2012 - 01 Jan 2014
Senior Vice President Discovery
Pharmos, ltd., Reẖovot, Israel
01 Oct 2005 - 01 Oct 2008
Senior Scientist or Principal Investigator
Proteologics, Ltd., Reẖovot, Israel
01 Sep 1999 - 01 Sep 2005
Post Doctoral Researcher
Weizmann Institute of Science, Reẖovot, Israel
01 Apr 1994 - 01 Sep 1999
Graduate Student or Post Graduate
Weill Cornell, New York, USA
01 Sep 1989 - 01 Feb 1994